Detalhe da pesquisa
1.
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis.
BMC Cancer
; 22(1): 1119, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319973
2.
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma.
Gynecol Oncol
; 167(2): 226-233, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055813
3.
Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer.
Future Oncol
; 13(9): 777-786, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28045335
4.
Comparison of oncology drug approval between Health Canada and the US Food and Drug Administration.
Cancer
; 121(10): 1688-93, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25604014
5.
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia.
Gynecol Oncol
; 137(2): 216-22, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25769658
6.
Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.
Int J Cancer
; 132(7): 1547-55, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22948899
7.
A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer.
Ther Adv Med Oncol
; 15: 17588359231157633, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36950270
8.
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.
Can J Kidney Health Dis
; 8: 20543581211057708, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820133
9.
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium.
Int J Gynecol Cancer
; 20(5): 787-93, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20847613
10.
Trends in the application of dynamic allocation methods in multi-arm cancer clinical trials.
Clin Trials
; 7(3): 227-34, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20406744
11.
DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report.
Pharmaceutics
; 11(5)2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31052357
12.
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial.
Clin Colorectal Cancer
; 17(3): 231-239.e7, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653857
13.
Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer.
Future Oncol
; 3(3): 247-54, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17547518
14.
Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag?
J Clin Oncol
; 25(16): 2159-61, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17538158